View ValuationPerk Labs 将来の成長Future 基準チェック /06現在、 Perk Labsの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Software 収益成長15.9%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Jun 14Perk Labs Inc. announced that it expects to receive CAD 2.5 million in fundingPerk Labs Inc. announced a non-brokered private placements of units and convertible debentures on June 12, 2024. The Company is proposing a new non-brokered private placement of up to 115,384,615 units at a price of CAD 0.013 per Unit for gross proceeds of up to CAD 1,499,999.995 and convertible debentures for gross proceeds of up to CAD 1,000,000; aggregate gross proceeds of CAD 2,499,999.995. Each Unit will consist of one common share and one Common Share purchase warrant. Each Warrant will entitle the holder to purchase one additional Common Share at a price of CAD 0.05 per Common Share for a period of 24 months from the Closing. The convertible debentures will be offered for a 2-year term at an interest rate of 15% and will be convertible into common shares of Perk Labs at a conversion price of CAD 0.05 per share. The private placements of the Units and the convertible debentures are expected to close on or before June 29, 2024. The Closing is subject to customary closing conditions, including, but not limited to, the receipt of all necessary approvals. All securities issued pursuant to the private placements will be subject to a statutory hold period of four months and one day following the Closing. A finder’s fee may be payable in connection with the Private Placements.New Risk • May 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended August 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (55% average daily change). Revenue is less than US$1m (CA$63k revenue, or US$46k). Market cap is less than US$10m (€5.08m market cap, or US$5.51m). Minor Risks Latest financial reports are more than 6 months old (reported August 2023 fiscal period end). Shareholders have been diluted in the past year (22% increase in shares outstanding).お知らせ • Apr 26Perk Labs Inc. announced that it has received CAD 1.714 million in fundingOn April 25, 2024, Perk Labs Inc. closed the transaction. The company announced that it has issued 78,900,000 units at a price of CAD 0.01 per unit for the gross proceeds of CAD 789,000 and 15% convertible debentures for the gross proceeds of CAD 25,000; aggregate gross proceeds of CAD 814,000 in third and final tranche. Each Unit consists of one common share and one Common Share purchase warrant. Each Warrant will entitle the holder to purchase one additional Common Share at a price of CAD 0.05 per Common Share for a period of 24 months from the closing. The Debentures mature two years from the date of issuance and bear interest at a rate of 15% per annum. The Debentures are convertible into Common Shares at a conversion price of CAD 0.05 per Common Share, subject to the terms and conditions set forth in the specific Debenture agreement. All securities issued pursuant to the private placements are subject to a statutory hold period of four months and one day following the closing. In connection with private placements, B. Rogic acquired CAD 73,000 of UnitsBoard Change • Dec 20Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Larry Timlick was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Dec 14+ 1 more updatePerk Labs Inc. Announces Issuance of U.S. PatentPerk Labs Inc. announced the issuance of its United States patent that protects the Company's rights to one of its inventions for systems and methods for electronic payments with fraud prevention, based on correlating transaction data and information from a user's device.Reported Earnings • Nov 01Third quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.005 loss in 3Q 2022)Third quarter 2023 results: CA$0.001 loss per share (improved from CA$0.005 loss in 3Q 2022). Net loss: CA$591.6k (loss narrowed 34% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 48% per year, which means it is significantly lagging earnings.お知らせ • Sep 29Perk Labs Inc. announced that it has received CAD 0.471 million in fundingOn September 28, 2023, Perk Labs Inc. closed the transaction. The company issued 1,312,500 units at an issue price of CAD 0.016 per unit for the gross proceeds of CAD 21,000 and convertible debentures for the gross proceeds of CAD 450,000; aggregate gross proceeds of CAD 471,000. Each Unit consists of one common share and one Common Share purchase warrant. Each Warrant will entitle the holder to purchase one additional Common Share at a price of CAD 0.05 per Common Share for a period of 24 months from the closing. The Debentures mature one year from the date of issuance and bear interest at a rate of 15% per annum. The Debentures are convertible into Common Shares at a conversion price of CAD 0.05 per Common Share. All securities issued pursuant to the private placements are subject to a statutory hold period of four months and one day following the closing. The bonds will mature on September 28, 2024.Reported Earnings • Aug 02Second quarter 2023 earnings released: CA$0.002 loss per share (vs CA$0.008 loss in 2Q 2022)Second quarter 2023 results: CA$0.002 loss per share (improved from CA$0.008 loss in 2Q 2022). Net loss: CA$691.1k (loss narrowed 55% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has fallen by 49% per year, which means it is significantly lagging earnings.お知らせ • Jul 15+ 1 more updatePerk Labs Inc. announced that it expects to receive CAD 0.35 million in fundingPerk Labs Inc. announced a non-brokered private placement of 6,250,000 units at an issue price of CAD 0.016 per unit for the gross proceeds of up to CAD 100,000 and convertible debentures for the gross proceeds of CAD 250,000, for the aggregate gross proceeds of CAD 350,000 on July 14, 2023. Each Unit will consist of one common share and one Common Share purchase warrant. Each Warrant will entitle the holder to purchase one additional Common Share at a price of CAD 0.05 per common share for a period of 24 months from the Closing. The convertible debentures will be offered on varying terms, including interest rates ranging from 5% to 15% and differing acceleration terms and maturity dates specific to the terms of each convertible debenture agreement. The convertible debentures will be convertible into common shares of Perk Labs at a conversion price of CAD 0.05 per share, subject to the terms and conditions set forth in the specific convertible debenture agreement. The Closing is subject to customary closing conditions, including, but not limited to, the receipt of all necessary approvals. All securities issued pursuant to the private placement will be subject to a statutory hold period of four months and one day following the Closing. The private placement of the Units and the convertible debentures is expected to close on or before August 24, 2023.お知らせ • Jul 10Perk Labs Inc. Announces Patrick Power Resigns from BoardPerk Labs Inc. at its Annual General Meeting of Shareholders held on July 5, 2023, announced Patrick Power has submitted his resignation to the Board. After review and consideration, the Board has accepted Mr. Power's resignation.Board Change • Jun 02Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Larry Timlick was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • May 25Perk Labs Inc., Annual General Meeting, Jul 05, 2023Perk Labs Inc., Annual General Meeting, Jul 05, 2023.Reported Earnings • May 01First quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 1Q 2022)First quarter 2023 results: CA$0.001 loss per share (improved from CA$0.002 loss in 1Q 2022). Revenue: CA$2.7k (down 70% from 1Q 2022). Net loss: CA$152.4k (loss narrowed 62% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings.Recent Insider Transactions • Mar 10Insider recently bought €924k worth of stockOn the 1st of March, Benoit Lacroix bought around 54m shares on-market at roughly €0.017 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €935k more in shares than they have sold in the last 12 months.Reported Earnings • Feb 22Full year 2022 earnings released: CA$0.017 loss per share (vs CA$0.009 loss in FY 2021)Full year 2022 results: CA$0.017 loss per share (further deteriorated from CA$0.009 loss in FY 2021). Net loss: CA$3.38m (loss widened 127% from FY 2021). Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has fallen by 60% per year, which means it is significantly lagging earnings.お知らせ • Jan 21Perk Labs Inc. Announces CFO TransitionPerk Labs Inc. announced that effective February 17, 2023, Andrew Bailes, a seasoned finance executive, will succeed Ms. Altamirano as Interim CFO until a permanent CFO is named. Vanessa Altamirano will step down effective February 17, 2023 to pursue another professional opportunity. Perk is currently in the process of structuring a merger with Getit Technologies Inc. (‘Getit’), and as part of the process, the Company continues to review its team to optimise the integration of the two companies. Andrew Bailes is a Chartered Public Accountant, Principal at Hertford Advisors and has served in CFO roles since 2006. He has extensive experience in IT, Telecoms, Logistics, manufacturing and other sectors, managing finance and Legal, HR and Operational functions. Andrew did his undergraduate degree in Mathematics and Management Studies at Cambridge University in the UK and was top in his Executive MBA at Cornell and Queens. His notable achievements include: CFO for various capital raises totaling over $100 million Negotiation of many multi-million dollar debt facilities Head of a 25-man Finance Department at one of Ottawa's larger production facilities Twenty-five years' experience in Business and Strategic planning .お知らせ • Jan 05Perk Labs Inc. Appoints Patrick Power to the Board of DirectorsPerk Labs Inc. announced that it has appointed Mr. Patrick Power to the company's board of directors, effective immediately. Mr. Power brings a wealth of experience in business and finance to the board. He is the Chairman and President of James Edward Capital Corporation, an Ottawa-based boutique investment bank focused on emerging growth companies and is advising the Company on its strategic options. Mr. Power has significant experience in finance and governance, having previously served in senior executive roles for several TSX/TSXV-listed technology companies.Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. Member of Advisory Board Neil Crist was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • Sep 29Third quarter 2022 earnings released: CA$0.005 loss per share (vs CA$0.006 loss in 3Q 2021)Third quarter 2022 results: CA$0.005 loss per share (improved from CA$0.006 loss in 3Q 2021). Net loss: CA$890.7k (loss narrowed 18% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.Board Change • Aug 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. Member of Advisory Board Neil Crist was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Reported Earnings • Jul 29Second quarter 2022 earnings released: CA$0.008 loss per share (vs CA$0.008 loss in 2Q 2021)Second quarter 2022 results: CA$0.008 loss per share (vs CA$0.008 loss in 2Q 2021). Net loss: CA$1.52m (loss widened 13% from 2Q 2021). Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 40% per year, which means it is significantly lagging earnings.Reported Earnings • May 01First quarter 2022 earnings released: CA$0.002 loss per share (vs CA$0.01 profit in 1Q 2021)First quarter 2022 results: CA$0.002 loss per share (down from CA$0.01 profit in 1Q 2021). Net loss: CA$405.7k (down 125% from profit in 1Q 2021). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings.Reported Earnings • Mar 04Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: CA$0.009 loss per share (up from CA$0.032 loss in FY 2020). Net loss: CA$1.49m (loss narrowed 67% from FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has fallen by 38% per year, which means it is significantly lagging earnings.Reported Earnings • Oct 30Third quarter 2021 earnings released: CA$0.006 loss per share (vs CA$0.005 loss in 3Q 2020)Third quarter 2021 results: Net loss: CA$1.08m (loss widened 45% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 36% per year, which means it is significantly lagging earnings.Reported Earnings • Jul 30Second quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.009 loss in 2Q 2020)Second quarter 2021 results: Net loss: CA$1.35m (loss widened 11% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has fallen by 38% per year, which means it is significantly lagging earnings.Reported Earnings • May 01First quarter 2021 earnings released: EPS CA$0.01 (vs CA$0.009 loss in 1Q 2020)First quarter 2021 results: Net income: CA$1.59m (up CA$2.81m from 1Q 2020). Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.Reported Earnings • Mar 27Full year 2020 earnings released: CA$0.032 loss per share (vs CA$0.059 loss in FY 2019)Full year 2020 results: Net loss: CA$4.49m (loss narrowed 44% from FY 2019). Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has fallen by 41% per year, which means it is significantly lagging earnings.Reported Earnings • Oct 29Third quarter earnings releasedOver the last 12 months the company has reported total losses of CA$5.50m, with losses narrowing by 13% from the prior year. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Perk Labs は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測DB:PKLB - アナリストの将来予測と過去の財務データ ( )CAD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数8/31/20230-2-1-1N/A5/31/20230-2-1-1N/A2/28/20230-3-2-2N/A11/30/20220-3-2-2N/A8/31/20220-3-3-3N/A5/31/20220-4-2-2N/A2/28/20220-4-2-2N/A11/30/20210-1-2-2N/A8/31/20210-2-2-2N/A5/31/20210-2-2-2N/A2/28/20210-2-2-2N/A11/30/20200-4-2-2N/A8/31/20200-5-2-2N/A5/31/20200-8-3-3N/A2/29/20200-14-4-4N/A11/30/20190-8-5-5N/A8/31/20190-6-6-6N/A5/31/20191-6-8-8N/A2/28/20191-3-10-10N/A11/30/20182-13-16-14N/A8/31/20182-18-17-16N/A5/31/20182-17-15-14N/A2/28/20182-14-13-12N/A11/30/20171-10-7-6N/A8/31/20170-5-4-4N/A5/31/20170-4N/A-3N/A2/28/20170-3N/A-2N/A11/30/20160-2N/A-1N/A8/31/20160-1N/A-1N/A5/31/2016N/A-1N/A-1N/A2/29/2016N/A-1N/A0N/A11/30/2015N/A-1N/A0N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: PKLBの予測収益成長が 貯蓄率 ( 0.8% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: PKLBの収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: PKLBの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: PKLBの収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: PKLBの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: PKLBの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YSoftware 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/10/05 16:56終値2024/07/08 00:00収益2023/08/31年間収益2022/11/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Perk Labs Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jun 14Perk Labs Inc. announced that it expects to receive CAD 2.5 million in fundingPerk Labs Inc. announced a non-brokered private placements of units and convertible debentures on June 12, 2024. The Company is proposing a new non-brokered private placement of up to 115,384,615 units at a price of CAD 0.013 per Unit for gross proceeds of up to CAD 1,499,999.995 and convertible debentures for gross proceeds of up to CAD 1,000,000; aggregate gross proceeds of CAD 2,499,999.995. Each Unit will consist of one common share and one Common Share purchase warrant. Each Warrant will entitle the holder to purchase one additional Common Share at a price of CAD 0.05 per Common Share for a period of 24 months from the Closing. The convertible debentures will be offered for a 2-year term at an interest rate of 15% and will be convertible into common shares of Perk Labs at a conversion price of CAD 0.05 per share. The private placements of the Units and the convertible debentures are expected to close on or before June 29, 2024. The Closing is subject to customary closing conditions, including, but not limited to, the receipt of all necessary approvals. All securities issued pursuant to the private placements will be subject to a statutory hold period of four months and one day following the Closing. A finder’s fee may be payable in connection with the Private Placements.
New Risk • May 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended August 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (55% average daily change). Revenue is less than US$1m (CA$63k revenue, or US$46k). Market cap is less than US$10m (€5.08m market cap, or US$5.51m). Minor Risks Latest financial reports are more than 6 months old (reported August 2023 fiscal period end). Shareholders have been diluted in the past year (22% increase in shares outstanding).
お知らせ • Apr 26Perk Labs Inc. announced that it has received CAD 1.714 million in fundingOn April 25, 2024, Perk Labs Inc. closed the transaction. The company announced that it has issued 78,900,000 units at a price of CAD 0.01 per unit for the gross proceeds of CAD 789,000 and 15% convertible debentures for the gross proceeds of CAD 25,000; aggregate gross proceeds of CAD 814,000 in third and final tranche. Each Unit consists of one common share and one Common Share purchase warrant. Each Warrant will entitle the holder to purchase one additional Common Share at a price of CAD 0.05 per Common Share for a period of 24 months from the closing. The Debentures mature two years from the date of issuance and bear interest at a rate of 15% per annum. The Debentures are convertible into Common Shares at a conversion price of CAD 0.05 per Common Share, subject to the terms and conditions set forth in the specific Debenture agreement. All securities issued pursuant to the private placements are subject to a statutory hold period of four months and one day following the closing. In connection with private placements, B. Rogic acquired CAD 73,000 of Units
Board Change • Dec 20Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Larry Timlick was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Dec 14+ 1 more updatePerk Labs Inc. Announces Issuance of U.S. PatentPerk Labs Inc. announced the issuance of its United States patent that protects the Company's rights to one of its inventions for systems and methods for electronic payments with fraud prevention, based on correlating transaction data and information from a user's device.
Reported Earnings • Nov 01Third quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.005 loss in 3Q 2022)Third quarter 2023 results: CA$0.001 loss per share (improved from CA$0.005 loss in 3Q 2022). Net loss: CA$591.6k (loss narrowed 34% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 48% per year, which means it is significantly lagging earnings.
お知らせ • Sep 29Perk Labs Inc. announced that it has received CAD 0.471 million in fundingOn September 28, 2023, Perk Labs Inc. closed the transaction. The company issued 1,312,500 units at an issue price of CAD 0.016 per unit for the gross proceeds of CAD 21,000 and convertible debentures for the gross proceeds of CAD 450,000; aggregate gross proceeds of CAD 471,000. Each Unit consists of one common share and one Common Share purchase warrant. Each Warrant will entitle the holder to purchase one additional Common Share at a price of CAD 0.05 per Common Share for a period of 24 months from the closing. The Debentures mature one year from the date of issuance and bear interest at a rate of 15% per annum. The Debentures are convertible into Common Shares at a conversion price of CAD 0.05 per Common Share. All securities issued pursuant to the private placements are subject to a statutory hold period of four months and one day following the closing. The bonds will mature on September 28, 2024.
Reported Earnings • Aug 02Second quarter 2023 earnings released: CA$0.002 loss per share (vs CA$0.008 loss in 2Q 2022)Second quarter 2023 results: CA$0.002 loss per share (improved from CA$0.008 loss in 2Q 2022). Net loss: CA$691.1k (loss narrowed 55% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has fallen by 49% per year, which means it is significantly lagging earnings.
お知らせ • Jul 15+ 1 more updatePerk Labs Inc. announced that it expects to receive CAD 0.35 million in fundingPerk Labs Inc. announced a non-brokered private placement of 6,250,000 units at an issue price of CAD 0.016 per unit for the gross proceeds of up to CAD 100,000 and convertible debentures for the gross proceeds of CAD 250,000, for the aggregate gross proceeds of CAD 350,000 on July 14, 2023. Each Unit will consist of one common share and one Common Share purchase warrant. Each Warrant will entitle the holder to purchase one additional Common Share at a price of CAD 0.05 per common share for a period of 24 months from the Closing. The convertible debentures will be offered on varying terms, including interest rates ranging from 5% to 15% and differing acceleration terms and maturity dates specific to the terms of each convertible debenture agreement. The convertible debentures will be convertible into common shares of Perk Labs at a conversion price of CAD 0.05 per share, subject to the terms and conditions set forth in the specific convertible debenture agreement. The Closing is subject to customary closing conditions, including, but not limited to, the receipt of all necessary approvals. All securities issued pursuant to the private placement will be subject to a statutory hold period of four months and one day following the Closing. The private placement of the Units and the convertible debentures is expected to close on or before August 24, 2023.
お知らせ • Jul 10Perk Labs Inc. Announces Patrick Power Resigns from BoardPerk Labs Inc. at its Annual General Meeting of Shareholders held on July 5, 2023, announced Patrick Power has submitted his resignation to the Board. After review and consideration, the Board has accepted Mr. Power's resignation.
Board Change • Jun 02Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Larry Timlick was the last independent director to join the board, commencing their role in 2017. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • May 25Perk Labs Inc., Annual General Meeting, Jul 05, 2023Perk Labs Inc., Annual General Meeting, Jul 05, 2023.
Reported Earnings • May 01First quarter 2023 earnings released: CA$0.001 loss per share (vs CA$0.002 loss in 1Q 2022)First quarter 2023 results: CA$0.001 loss per share (improved from CA$0.002 loss in 1Q 2022). Revenue: CA$2.7k (down 70% from 1Q 2022). Net loss: CA$152.4k (loss narrowed 62% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has fallen by 52% per year, which means it is significantly lagging earnings.
Recent Insider Transactions • Mar 10Insider recently bought €924k worth of stockOn the 1st of March, Benoit Lacroix bought around 54m shares on-market at roughly €0.017 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €935k more in shares than they have sold in the last 12 months.
Reported Earnings • Feb 22Full year 2022 earnings released: CA$0.017 loss per share (vs CA$0.009 loss in FY 2021)Full year 2022 results: CA$0.017 loss per share (further deteriorated from CA$0.009 loss in FY 2021). Net loss: CA$3.38m (loss widened 127% from FY 2021). Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has fallen by 60% per year, which means it is significantly lagging earnings.
お知らせ • Jan 21Perk Labs Inc. Announces CFO TransitionPerk Labs Inc. announced that effective February 17, 2023, Andrew Bailes, a seasoned finance executive, will succeed Ms. Altamirano as Interim CFO until a permanent CFO is named. Vanessa Altamirano will step down effective February 17, 2023 to pursue another professional opportunity. Perk is currently in the process of structuring a merger with Getit Technologies Inc. (‘Getit’), and as part of the process, the Company continues to review its team to optimise the integration of the two companies. Andrew Bailes is a Chartered Public Accountant, Principal at Hertford Advisors and has served in CFO roles since 2006. He has extensive experience in IT, Telecoms, Logistics, manufacturing and other sectors, managing finance and Legal, HR and Operational functions. Andrew did his undergraduate degree in Mathematics and Management Studies at Cambridge University in the UK and was top in his Executive MBA at Cornell and Queens. His notable achievements include: CFO for various capital raises totaling over $100 million Negotiation of many multi-million dollar debt facilities Head of a 25-man Finance Department at one of Ottawa's larger production facilities Twenty-five years' experience in Business and Strategic planning .
お知らせ • Jan 05Perk Labs Inc. Appoints Patrick Power to the Board of DirectorsPerk Labs Inc. announced that it has appointed Mr. Patrick Power to the company's board of directors, effective immediately. Mr. Power brings a wealth of experience in business and finance to the board. He is the Chairman and President of James Edward Capital Corporation, an Ottawa-based boutique investment bank focused on emerging growth companies and is advising the Company on its strategic options. Mr. Power has significant experience in finance and governance, having previously served in senior executive roles for several TSX/TSXV-listed technology companies.
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. Member of Advisory Board Neil Crist was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • Sep 29Third quarter 2022 earnings released: CA$0.005 loss per share (vs CA$0.006 loss in 3Q 2021)Third quarter 2022 results: CA$0.005 loss per share (improved from CA$0.006 loss in 3Q 2021). Net loss: CA$890.7k (loss narrowed 18% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings.
Board Change • Aug 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 10 experienced directors. No highly experienced directors. Member of Advisory Board Neil Crist was the last director to join the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Reported Earnings • Jul 29Second quarter 2022 earnings released: CA$0.008 loss per share (vs CA$0.008 loss in 2Q 2021)Second quarter 2022 results: CA$0.008 loss per share (vs CA$0.008 loss in 2Q 2021). Net loss: CA$1.52m (loss widened 13% from 2Q 2021). Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 40% per year, which means it is significantly lagging earnings.
Reported Earnings • May 01First quarter 2022 earnings released: CA$0.002 loss per share (vs CA$0.01 profit in 1Q 2021)First quarter 2022 results: CA$0.002 loss per share (down from CA$0.01 profit in 1Q 2021). Net loss: CA$405.7k (down 125% from profit in 1Q 2021). Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings.
Reported Earnings • Mar 04Full year 2021 earnings: Revenues and EPS in line with analyst expectationsFull year 2021 results: CA$0.009 loss per share (up from CA$0.032 loss in FY 2020). Net loss: CA$1.49m (loss narrowed 67% from FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has fallen by 38% per year, which means it is significantly lagging earnings.
Reported Earnings • Oct 30Third quarter 2021 earnings released: CA$0.006 loss per share (vs CA$0.005 loss in 3Q 2020)Third quarter 2021 results: Net loss: CA$1.08m (loss widened 45% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 36% per year, which means it is significantly lagging earnings.
Reported Earnings • Jul 30Second quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.009 loss in 2Q 2020)Second quarter 2021 results: Net loss: CA$1.35m (loss widened 11% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has fallen by 38% per year, which means it is significantly lagging earnings.
Reported Earnings • May 01First quarter 2021 earnings released: EPS CA$0.01 (vs CA$0.009 loss in 1Q 2020)First quarter 2021 results: Net income: CA$1.59m (up CA$2.81m from 1Q 2020). Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.
Reported Earnings • Mar 27Full year 2020 earnings released: CA$0.032 loss per share (vs CA$0.059 loss in FY 2019)Full year 2020 results: Net loss: CA$4.49m (loss narrowed 44% from FY 2019). Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has fallen by 41% per year, which means it is significantly lagging earnings.
Reported Earnings • Oct 29Third quarter earnings releasedOver the last 12 months the company has reported total losses of CA$5.50m, with losses narrowing by 13% from the prior year.